Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Mucus tethering in asthma

In patients with stable asthma, the accumulation of pathogenic mucus, which is not readily cleared from the lungs, can result in asphyxiation. The factors that underlie the decreased ability to transport asthma-associated mucus out of the airways are unclear, and little is known about the composition and organization of this mucus. Luke Bonser and colleagues at the University of California San Francisco evaluated mucus plugs from individuals with fatal asthma and determined that these plugs are heterogeneous gels with distinct mucin-containing domains. The majority these domains were composed of MUC5AC, some domains contained only MUC5B, and a small fraction had both MUC5AC and MUC5B. Cultured human bronchial cells from donors without asthma produced a uniform MUC5B-containing gel; however, stimulation of these cultures with the asthma-associated cytokine IL-13 resulted in formation of heterogeneous, MUC5AC-containing mucus. IL-13 treatment impaired mucus transport, but not as the result of the loss of cilia function. Instead, MUC5AC-containing domains were tethered to the epithelial surface and could not be washed from IL-13-treated human bronchial cells. Removal of tethered mucus from the apical surface with a reducing agent restored mucus transport. Together, these results indicate that epithelial tethering of mucus contributes to airway obstruction in asthma. The accompanying image shows mucin staining (MUC5B, red; MUC5AC, green; DAPI, blue) in the airways of individuals without asthma (top, left), individuals with fatal asthma (bottom, left), and in untreated human bronchial epithelial cells (top, right), and IL-13-stimulated human bronchial epithelial cells (bottom, right). Note the predominance of MUC5AC (green) in both fatal asthma and IL-13-stimulated human bronchial epithelial cells.

Published May 16, 2016, by Corinne Williams

Scientific Show StopperPulmonology

Related articles

Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma
Luke R. Bonser, … , Walter Finkbeiner, David J. Erle
Luke R. Bonser, … , Walter Finkbeiner, David J. Erle
Published May 16, 2016
Citation Information: J Clin Invest. 2016;126(6):2367-2371. https://doi.org/10.1172/JCI84910.
View: Text | PDF
Brief Report Pulmonology

Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma

  • Text
  • PDF
Abstract

The development of pathologic mucus, which is not readily cleared from the airways, is an important contributor to the morbidity and mortality associated with asthma. It is not clear how the major airway mucins MUC5AC and MUC5B are organized within the mucus gel or how this gel contributes to airway obstruction in asthma. Here, we demonstrated that mucus plugs from individuals with fatal asthma are heterogeneous gels with distinct MUC5AC- and MUC5B-containing domains. Stimulation of cultured human bronchial epithelial cells with IL-13, a key mediator in asthma, induced the formation of heterogeneous mucus gels and dramatically impaired mucociliary transport. Impaired transport was not associated with defects in ciliary function but instead was related to tethering of MUC5AC-containing mucus gel domains to mucus-producing cells in the epithelium. Replacement of tethered mucus with untethered mucus restored mucociliary transport. Together, our results indicate that tethering of MUC5AC-containing domains to the epithelium causes mucostasis and likely represents a major cause of mucus plugging in asthma.

Authors

Luke R. Bonser, Lorna Zlock, Walter Finkbeiner, David J. Erle

×
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts